text
"['\n4. 매출 및 수주상황\n가. 매출현황\n(단위 : 백만원)\n매출유형\n질환군\n품목\n제61기 3분기\n제60기\n제59기\n제/상품\n고혈압/이상지질혈증\n카나브 패밀리\n내수\n111,411\n152,043\n130,238\n수출\n2,361\n3,131\n4,249\n바이오아스트릭스\n내수\n9,611\n14,046\n14,980\n기타\n내수\n9,408\n25,131\n24,979\n항암\n온베브지\n내수\n34,573\n39,627\n19,326\n뉴라스타\n내수\n23,326\n31,758\n34,622\n알림타\n내수\n30,554\n22,613\n785\n그라신\n내수\n15,446\n21,210\n17,599\n젬자\n내수\n14,896\n16,940\n10,911\n젤로다\n내수\n9,834\n14,029\n12,686\n캠푸토\n내수\n8,456\n12,457\n9,799\n탁솔\n내수\n7,829\n6,259\n0\n기타\n내수\n43,895\n52,073\n54,898\nSC\n뮤코미스트\n내수\n15,874\n21,844\n14,870\n메이액트\n내수\n11,797\n21,752\n14,538\n올리멜\n내수\n15,076\n20,502\n15,693\n스토가\n내수\n10,134\n15,489\n17,587\n맥스핌\n내수\n9,011\n14,060\n12,164\n나제론\n내수\n6,928\n11,052\n10,303\n기타\n내수\n147,185\n61,795\n53,672\n수출\n3,406\n5,231\n7,197\n당뇨\n트루리시티\n내수\n26,599\n47,872\n54,172\n기타\n내수\n10,238\n6,590\n163\nRenal\n헤모시스\n내수\n17,938\n21,222\n19,066\n기타\n내수\n32,825\n33,732\n36,146\nCNS\n자이프렉사\n내수\n12,584\n14,651\n13,106\n기타\n내수\n2,513\n10,209\n13,498\nOTC\n겔포스\n내수\n10,382\n14,190\n12,885\n수출\n4,663\n2,065\n9,075\n용각산\n내수\n16,155\n23,682\n21,294\n기타\n내수\n33,052\n37,740\n35,446\n수탁\n내수\n52,649\n63,234\n59,933\n기타\n내수\n(417)\n1,397\n4,595\n합계\n760,192\n859,626\n760,475\n나. 판매경로\n(1) 내수의 경우 \xa0·공장→창고→병ㆍ의원, 약국→소비자 \xa0·공장→창고→도매상→병ㆍ의원, 약국→소비자(2) 수출의 경우 \xa0·L/C입수→공장출고→물품선적→B/L입수(선사)→수입상→NEGO(대금수령)다. 판매방법 및 조건\n(1) 내수의 경우 \xa0·병ㆍ의원, 약국, 도매상에 현금, 어음 및 카드판매(2) 수출의 경우 \xa0·신용장에 의한 판매(L/C BASE) \xa0·구매승인서에 의한 판매\n']"
